Untreated Sleep Apnea Linked to Significantly Higher Risk of Parkinson’s Disease in Major Veteran Study

New clinical evidence suggests a profound connection between untreated obstructive sleep apnea (OSA) and the subsequent development of Parkinson’s disease, marking a significant milestone in our understanding of neurodegenerative health. According to a comprehensive study published on November 24 in JAMA Neurology, individuals who suffer from sleep apnea but do not seek or maintain treatment face a dramatically higher likelihood of being diagnosed with Parkinson’s disease later in life. Conversely, the consistent use of continuous positive airway pressure (CPAP) therapy appears to serve as a protective measure, potentially mitigating this risk by maintaining stable oxygen levels and improving overall sleep architecture.

The research, led by a collaborative team from Oregon Health & Science University (OHSU) and the Portland VA Health Care System, represents one of the largest longitudinal analyses of its kind. By examining the electronic health records of more than 11 million U.S. military veterans between 1999 and 2022, investigators were able to track health outcomes over two decades, providing a robust statistical foundation for their conclusions. The findings suggest that sleep health is not merely a matter of daytime fatigue but a critical pillar in the long-term prevention of neurological decay.

The Scope of the Study and Methodology

The sheer scale of the study—utilizing data from the Department of Veterans Affairs—allowed researchers to observe trends that might be invisible in smaller clinical trials. The VA health system provides a unique longitudinal perspective, as many veterans remain within the system for decades, allowing for the tracking of chronic conditions from onset through progression.

Researchers focused on veterans who had been diagnosed with obstructive sleep apnea, a condition characterized by repeated interruptions in breathing during sleep due to the collapse of upper airway tissues. They then cross-referenced these cases with subsequent diagnoses of Parkinson’s disease. To ensure the accuracy of the association, the team employed sophisticated statistical models to adjust for various "confounding factors." These included age, body mass index (BMI), high blood pressure (hypertension), and other cardiovascular markers that are often comorbid with both sleep apnea and neurodegenerative disorders.

Even after these adjustments, the data revealed a stark reality: veterans with untreated sleep apnea were nearly twice as likely to develop Parkinson’s disease compared to those without the condition or those who successfully managed it with CPAP therapy.

Understanding Parkinson’s Disease and Age-Related Risks

Parkinson’s disease is a progressive neurological disorder primarily known for affecting movement. It occurs when nerve cells in a specific part of the brain, the substantia nigra, become impaired or die. These cells normally produce dopamine, a chemical messenger that allows for smooth, coordinated muscle movement. As dopamine levels decrease, patients experience tremors, stiffness, slowness of movement, and balance issues.

Currently, an estimated 1 million people in the United States live with Parkinson’s, and that number is expected to rise as the population ages. While genetics play a role in a small percentage of cases, the vast majority of Parkinson’s diagnoses are "idiopathic," meaning the exact cause is unknown. However, age remains the primary risk factor; the probability of diagnosis increases significantly every year after age 60.

The OHSU study adds a critical piece to the puzzle of idiopathic Parkinson’s, suggesting that environmental and physiological stressors—such as chronic nighttime hypoxia (low oxygen levels) caused by sleep apnea—may act as a catalyst for the neurodegenerative process.

The Biological Mechanism: How Sleep Apnea Impacts the Brain

The link between sleep apnea and brain health is rooted in the physiological stress caused by intermittent hypoxia. When a person with OSA stops breathing, the oxygen saturation in their blood drops. This triggers a "fight or flight" response, causing the person to wake up briefly to gasp for air. This cycle can happen dozens, or even hundreds, of times per night.

"If you stop breathing and oxygen is not at a normal level, your neurons are probably not functioning at a normal level either," explained lead author Lee Neilson, M.D., an assistant professor of neurology at OHSU and a staff neurologist at the Portland VA.

Dr. Neilson and his colleagues hypothesize that this repeated deprivation of oxygen creates a state of oxidative stress and inflammation within the brain. Over years of untreated apnea, this stress may accelerate the accumulation of misfolded proteins, such as alpha-synuclein, which are the hallmarks of Parkinson’s disease. Furthermore, sleep is the period during which the brain’s glymphatic system—a waste-clearance mechanism—is most active. Disrupted sleep prevents the brain from "washing away" metabolic waste, potentially leading to the toxic buildup that characterizes neurodegeneration.

By using a CPAP machine, which delivers a steady stream of pressurized air through a mask to keep the airway open, patients maintain steady oxygen levels. This stability may provide the brain with the "resilience" needed to ward off the early stages of Parkinson’s.

The Role of CPAP as a Preventative Tool

Continuous positive airway pressure (CPAP) has long been the "gold standard" for treating sleep apnea, but patient compliance has historically been a challenge. Many patients find the masks uncomfortable or the sound of the machine intrusive. However, the findings of this study provide a powerful new incentive for patients to adhere to their treatment plans.

Co-author Gregory Scott, M.D., Ph.D., an assistant professor of pathology in the OHSU School of Medicine, noted that while a diagnosis of sleep apnea is not a "guarantee" of future Parkinson’s, the risk increase is significant enough to warrant serious attention.

"The veterans who use their CPAP love it," Scott said, noting that beyond the long-term neurological benefits, the immediate improvements in quality of life are profound. "They feel better, they’re less tired. Perhaps if others know about this reduction in risk of Parkinson’s disease, it will further convince people with sleep apnea to give CPAP a try."

Implications for Clinical Practice

The study’s results are expected to have an immediate impact on how neurologists and primary care physicians approach sleep health. For many years, sleep apnea was viewed primarily through the lens of cardiovascular health—linked to heart attacks and strokes. This new data shifts the focus toward the "brain-sleep axis."

Dr. Neilson indicated that the study has already influenced his clinical perspective. "I think it will change my practice," he said, emphasizing that he will now prioritize sleep apnea screenings and CPAP compliance as a core component of preventative neurology.

In a broader clinical sense, this research suggests that the window for intervening in Parkinson’s disease may exist decades before the first motor symptoms appear. If sleep apnea is identified and treated in a patient’s 40s or 50s, it may substantially alter their neurological health trajectory in their 70s and 80s.

Chronology of the Research and Institutional Support

The project was a massive undertaking that spanned several years of data extraction and analysis. The timeline of the data—1999 to 2022—covers a period of significant advancement in both sleep medicine and electronic health record keeping.

The research was a multi-institutional effort, involving:

• Oregon Health & Science University (OHSU): Providing academic and neurological expertise.
• Portland VA Health Care System: Providing the primary patient database and clinical oversight.
• University of Washington and VA Puget Sound Health Care System: Contributing additional research and data analysis through investigators like Dr. Jeffrey Iliff, a renowned expert in the brain’s waste-clearance systems.

The study received extensive funding from various prestigious organizations, reflecting its importance to public health. Support came from the Department of Veterans Affairs through multiple grant awards, the National Institute on Aging (part of the National Institutes of Health), the John and Tami Marick Family Foundation, and the Collins Medical Trust. Additionally, the U.S. Army Medical Research Acquisition Activity provided funding, highlighting the Department of Defense’s interest in the long-term health of service members.

Broader Impact and Future Directions

The findings published in JAMA Neurology contribute to a growing body of evidence suggesting that sleep is a modifiable risk factor for many forms of dementia and neurodegeneration. While this study focused on Parkinson’s, similar links have been explored regarding Alzheimer’s disease.

The association found in the veteran population is particularly poignant. Veterans often face higher rates of sleep disorders due to the physical and psychological rigors of service, including higher incidences of PTSD and traumatic brain injury (TBI), both of which can complicate sleep patterns. By identifying CPAP as a tool for "neuro-resilience," the VA can better tailor its long-term care strategies for aging veterans.

Moving forward, researchers hope to conduct prospective studies—where they follow patients in real-time rather than looking back at records—to further clarify the timing of the association. They also aim to investigate whether the severity of sleep apnea (measured by the number of times a person stops breathing per hour) correlates directly with the speed of Parkinson’s progression.

For the general public, the message is clear: snoring and daytime sleepiness should not be dismissed as mere inconveniences. They are potential indicators of obstructive sleep apnea, a condition that, if left untreated, may have far-reaching consequences for the health and longevity of the human brain. As medical science continues to bridge the gap between sleep and neurology, the humble CPAP machine may eventually be recognized not just as a sleep aid, but as a vital tool in the fight against Parkinson’s disease.